Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-25 @ 1:11 PM
Study NCT ID:
NCT06754059
Status:
RECRUITING
Last Update Posted:
2025-01-01
First Post:
2024-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC
Sponsor:
zhangjie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-23
First Submit QC Date:
None
Study First Post Date:
2024-12-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-30
Last Update Post Date:
2025-01-01
Last Update Post Date Type:
ACTUAL